Bicara Therapeutics Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Assets | |||
| Cash & Equivalents | $96.7M | $489.7M | $230.4M |
| Accounts Receivable | — | — | — |
| Inventory | — | — | — |
| Total Current Assets | $422.1M | $502.5M | $231.1M |
| Property, Plant & Equipment | $330.0K | $155.0K | $202.0K |
| Goodwill | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — |
| Total Assets | $431.0M | $510.0M | $234.0M |
| Liabilities | |||
| Accounts Payable | — | — | — |
| Total Current Liabilities | $28.9M | $18.0M | $15.1M |
| Long-Term Debt | — | — | — |
| Total Liabilities | $29.5M | $18.1M | $15.5M |
| Stockholders' Equity | |||
| Retained Earnings | $-359.0M | $-221.0M | $-153.0M |
| Total Stockholders' Equity | $401.5M | $491.9M | $-148.8M |